Clinical Costing in Healthcare: Challenges Facing Facilities and the Role of Technology Solutions

Cyscode Technology · Research Report · 2026

Clinical costing, the practice of calculating the true, patient-level cost of delivering healthcare, has moved from a "nice-to-have" management tool to a regulatory mandate in leading healthcare markets, most notably under the Abu Dhabi Clinical Costing Standard (ADCCS) and Abu Dhabi Clinical Costing Guidelines (ADCCG) enforced by the Department of Health (DOH) via the Shafafiya platform. Despite its growing importance, most healthcare facilities are structurally unprepared to do it well. Three problems recur across the market:

1. A genuine expertise gap - clinical costing sits at the intersection of clinical operations, cost accounting, health information systems, and regulatory compliance, and very few professionals are trained across all four.
2. Weak underlying infrastructure - fragmented EMR, GL, and operational data that was never designed to be linked at the patient-encounter level.
3. A crowded, confusing vendor market - general IT companies, accounting/tax firms, and billing consultancies increasingly market themselves as "clinical costing experts," despite clinical costing requiring a distinct skill set that overlaps only partially with their core business.

This report examines each of these challenges in detail and reviews how purpose-built technology - using Cyscode Technology's Clinicost Engine (cyscode.ae) as a case example - is designed to close these gaps through automation, built-in regulatory logic, and standardized allocation methodologies. Importantly, Cyscode's team includes both clinical and financial experts who can interpret costing data and provide advisories, ensuring that technology is paired with domain expertise rather than offered as a black-box solution.

1. What Clinical Costing Is, and Why It Has Become Unavoidable

Clinical costing is the process of tracing the actual cost of delivering care down to the individual patient encounter or procedure, rather than relying on high-level departmental averages. It combines:

• Clinical data - diagnoses (ICD-10), procedures, length of stay, critical care/ventilation time, and other encounter-level detail.
• Financial data - the general ledger, broken into direct costs (salaries, consumables, drugs) and overhead costs (utilities, administration, facility costs).
• Activity-based allocation - assigning both direct and indirect costs to patients using drivers such as time spent, item counts, or Relative Value Units (RVUs).

In Abu Dhabi, this is no longer optional. The DOH's clinical costing mandate requires licensed providers to submit patient-level and encounter-level costing data through the Shafafiya platform in a standardized XML format, reconciled against the general ledger, with CFO attestation. Non-compliance risks submission rejection, resubmission cycles, and regulatory scrutiny. Similar activity-based, patient-level costing (PLICS) approaches have long been used in the UK and Australia to support value-based funding.

2. Core Challenges Facing Healthcare Facilities

2.1 The Expertise Gap

Clinical costing is not accounting, and it is not health IT - it is a hybrid discipline. A competent clinical costing function needs people who can simultaneously:

• Read and interpret clinical documentation (ICD/procedure coding, encounter types, clinical time metrics).
• Apply cost accounting methodologies correctly - particularly step-down and reciprocal allocation, which are materially more complex than simple per-diem or percentage-based allocation.
• Calculate RVUs accurately, since manual RVU estimation is prone to error and does not produce reproducible results.
• Understand the specific regulatory rulebook (in Abu Dhabi's case, 65+ ADCCG validation rules, XML schema requirements, and Shafafiya submission mechanics).

Very few hospitals - especially small and mid-sized clinics and day-care centers - have this combination of skills in-house. Finance teams are often unfamiliar with how to tag costs to clinical terms such as diagnosis, medication, or consultant activity, while clinical operations staff are unfamiliar with cost accounting. This mismatch is a primary driver of submission errors and rejections.

2.2 Infrastructure Limitations

Even where expertise exists, the underlying data infrastructure is frequently not built for costing:

• Data silos across finance, pharmacy, HR, clinical operations, and EMR systems delay consolidation and introduce inconsistencies.
• Generic ERP or accounting software rarely supports cost mapping at the encounter level - it was designed for facility- or department-level financial reporting, not patient-level activity-based costing.
• Manual spreadsheet-based processes remain common, creating scope for misallocation, duplication, or missed procedures, and typically take three to six months of manual effort per costing cycle.
• No audit trail. Spreadsheet-driven costing is difficult to reconcile or defend if challenged by a regulator, since calculations are not consistently traceable back to source data.
• Data security and governance risk. Sensitive clinical and financial data is sometimes shared with third-party intermediaries during manual processing, which raises exposure under frameworks like ADHICS (Abu Dhabi Healthcare Information and Cyber Security Standard).

2.3 A Confusing and Sometimes Misleading Vendor Market

Because clinical costing is new, mandatory, and technically demanding, it has attracted a wide range of service providers positioning themselves as specialists. In practice, the market includes at least three distinct types of vendor, and facilities often struggle to tell them apart:

• Purpose-built clinical costing platforms, engineered specifically around the regulatory standard (encounter-level costing engines, allocation logic, and direct Shafafiya submission built in from the ground up).
• General health IT / EMR / billing vendors that add clinical costing as a module or service line on top of software originally built for other purposes (e.g., claims, revenue cycle management, or general ERP).
• Accounting, tax, and bookkeeping firms that have added "clinical costing" to a broader menu of services alongside VAT consulting, audit, payroll, and corporate tax advisory. This is a genuine and observable pattern in the current market - several UAE accounting and tax advisory firms now list clinical costing services alongside VAT return filing, statutory audit, and bookkeeping outsourcing on the same service pages.

This isn't necessarily evidence of bad faith on the part of any individual firm - accounting expertise is genuinely relevant to parts of the costing and reconciliation process. But it does mean that "clinical costing expertise" is not a protected or standardized credential, and a facility cannot assume that a vendor calling itself an expert has depth in activity-based clinical costing methodology, RVU calculation, or DOH-specific validation logic. The practical risk for a facility is:

• Engaging a provider whose core competency is bookkeeping or IT support, and discovering only after a rejected submission that they lack the clinical-financial hybrid expertise the standard actually requires.
• Paying for advisory or software services that produce technically compliant-looking output (an XML file, a spreadsheet) without the underlying allocation methodology being sound - which surfaces later as inconsistent figures, failed reconciliations, or DOH rejections.
• Losing months of runway toward a compliance deadline before the gap is discovered.

3. How Technology Platforms Are Addressing These Gaps

The response from the market to both the expertise gap and the infrastructure gap has been the emergence of dedicated clinical costing software platforms that embed regulatory and methodological expertise directly into the tool, rather than relying solely on the knowledge of whoever operates it. Cyscode Technology's Clinicost Engine (cyscode.ae) is one example of this category, purpose-built for the Abu Dhabi market.

3.1 What the Platform Does

According to Cyscode's own product documentation, Clinicost Engine is built specifically around the ADCCG/ADCCS framework rather than adapted from general-purpose accounting or ERP software. Its stated capabilities include:

• End-to-end workflow automation, from clinical and financial data ingestion through to XML generation and direct Shafafiya submission - reducing a process that traditionally takes three to six months of manual work down to a matter of days.
• Automated RVU calculation, addressing the specific problem that manual RVU estimation cannot produce exact, reproducible costing.
• 65+ built-in validation rules aligned to DOH/ADCCG requirements, designed to catch missing allocations, data inconsistencies, and compliance gaps before submission rather than after a rejection.
• Standardized cost allocation methodology, applying step-down and reciprocal allocation automatically across 15+ direct and overhead cost buckets, rather than relying on per-diem or percentage-based shortcuts.
• Reconciliation and WIP costing support, generating DOH reconciliation reports that compare total expenses against allocated costs, and handling Opening/Closing Work-in-Progress patient costing with CFO attestation.
• Enterprise-scale data handling, supporting millions of records and multi-facility organizational structures with a single unified integration layer (EMR, GL, and operational data).
• Audit-ready traceability, with complete audit trails, validation reports, and reconciliation outputs - addressing the "no audit trail" weakness of spreadsheet-based costing.
• Data governance, with the vendor stating the platform avoids sharing client data with third parties, positioning it as aligned with ADHICS cybersecurity requirements.

3.2 Why This Model Addresses the Root Problems

3.3 A Balanced View

It is worth noting that a technology platform reduces - but does not fully eliminate - the need for internal expertise. Facilities still need staff who understand their own clinical and financial data well enough to configure cost centers, map general ledger accounts to the correct cost buckets, and interpret the resulting reports for management decision-making. Software can enforce methodology and catch errors, but it cannot substitute for organizational understanding of why costs are being allocated a particular way. The most resilient approach combines a purpose-built platform with clinical and financial advisory support and at least a baseline of in-house or trained oversight, rather than treating either technology or outsourced "experts" as a complete substitute for internal capability.

4. Recommendations for Healthcare Facilities

1. Treat clinical costing as an ongoing program, not a one-off project. Regulatory requirements and standards continue to evolve (e.g., ADCCS updates), so a sustainable framework matters more than a single successful submission.
2. Separate software evaluation from vendor marketing claims. Request a live walkthrough of the allocation logic, validation rules, and audit trail - not just a sales deck.
3. Invest in a baseline of internal capability, even when outsourcing or using a platform, so the facility can interpret and act on the resulting cost data rather than treating it as a black-box compliance exercise.
4. Prioritize platforms with pre-submission validation against the actual regulatory rule set, since this is the single biggest lever for reducing costly rejection-and-resubmission cycles.
5. Audit data governance practices of any third party handling clinical and financial data, given the sensitivity of the information and applicable cybersecurity standards (e.g., ADHICS in Abu Dhabi).
6. Seek vendors with clinical and financial advisory expertise, not just software. The ability to interpret costing data and translate it into operational and financial guidance is as important as the technology itself.

5. Conclusion

Clinical costing has become a regulatory necessity for healthcare providers in markets like Abu Dhabi, but the path to compliance is genuinely difficult: it requires a rare combination of clinical, financial, and regulatory expertise; it depends on infrastructure most facilities were never built to support; and it is served by a vendor market where the line between deep domain specialists and generalist providers offering costing as an add-on service is not always obvious. Purpose-built platforms such as Cyscode's Clinicost Engine represent one response to this problem - embedding allocation methodology, RVU calculation, and DOH-specific validation directly into automated software rather than relying solely on the expertise of whoever is operating it. Critically, Cyscode supplements its technology with clinical and financial experts who can interpret costing data and provide advisories, ensuring that facilities receive both the tools and the guidance needed to achieve and sustain compliance. Facilities evaluating any clinical costing partner, software-based or advisory, are best served by testing specific methodological and validation claims directly rather than relying on marketing positioning alone.